Home › Funds › Commodore Capital LP › ENTX
Commodore Capital LP position in ENTX
ENTERA BIO LTD · Health Care
Commodore Capital LP reported holding 7,352,941 shares of ENTX (ENTERA BIO LTD) in its Q3 2026 13F filing — a position valued at US$21.4M, representing 1.66% of its reported portfolio and ranking #19 among its reported holdings. Commodore Capital LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Commodore Capital LP's ENTX position evolved
Commodore Capital LP first disclosed a stake in ENTX in Q3 2026 at 7,352,941 shares (US$21.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 7.35M | $21.40M | New |
About ENTX and 13F data
ENTX (ENTERA BIO LTD) is a Health Care company. 49 other funds we track also report a position in ENTX — the largest reported positions include BVF INC/IL (US$49.6M), Vivo Capital, LLC (US$35.7M), TCG Crossover Management, LLC (US$35.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENTX
- BVF INC/IL 17.05M sh · $49.62M · Q3 2026
- Vivo Capital, LLC 12.25M sh · $35.66M · Q3 2026
- TCG Crossover Management, LLC 12.25M sh · $35.66M · Q3 2026
- Spruce Street Capital LP 11.21M sh · $32.63M · Q3 2026
- Seven Fleet Capital Management LP 6.86M sh · $19.97M · Q3 2026
- Knoll Capital Management, LLC 5.83M sh · $16.97M · Q3 2026
- Venrock Adviser, LLC 5.11M sh · $14.86M · Q3 2026
- Logos Global Management LP 4.41M sh · $12.84M · Q3 2026
- Catalio Capital Management, LP 3.92M sh · $11.41M · Q3 2026
- NEXTBio Capital Management LP 2.92M sh · $8.51M · Q3 2026
- Foresite Capital Management VI LLC 1.23M sh · $3.57M · Q3 2026
- Gem Investment Advisors, LLC 19.14K sh · $55.68K · Q3 2026
More on Commodore Capital LP
FAQ
How long has Commodore Capital LP held ENTX?
Commodore Capital LP has disclosed ENTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Commodore Capital LP's current position in ENTX?
As of Q3 2026, Commodore Capital LP holds 7.35M shares of ENTX (ENTERA BIO LTD), valued at $21.40M, representing 1.66% of its reported portfolio and ranking #19.
Has Commodore Capital LP been buying or selling ENTX?
In the latest 13F filing (Q3 2026), Commodore Capital LP newly opened its position in ENTX.
Which other funds hold ENTX?
Other major institutional holders of ENTX include BVF INC/IL, Vivo Capital, LLC, TCG Crossover Management, LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.